<DOC>
	<DOC>NCT02725242</DOC>
	<brief_summary>This study will evaluate the efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg in the period of step down in well controlled asthmatic patient.</brief_summary>
	<brief_title>Efficacy of Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg in Step Down Asthma</brief_title>
	<detailed_description>The study will measure the efficacy of once daily low dose ICS/ LABA in well controlled asthmatic patient comparing with low dose ICS in step down circumstance.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthmatic patients who have well controlled asthma at least 12 weeks with using formoterol/budesonide (4.5/160) twice daily Age more than 18 yearold Patients who able to do spirometry without contraindication History smoking less than 10 packyears History of using systemic steroid previous 4 week and respiratory infection History of pulmonary tuberculosis with residual lung lesion by chest radiograph recent serious medical condition such as myocardial infarction, stroke, pneumonia etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>